Interview mit Fridtjof Traulsen (Boehringer Ingelheim) zu Diversity:: „Jeder Mensch verdient die gleichen Chancen und Rechte“
Der Vorsitzende der Geschäftsführung der Boehringer Ingelheim Deutschland GmbH über die Werte des biopharmazeutischen ...
With $66 million R&D center, Boehringer Ingelheim fulfills economic development pledge to state
The $66 million project is part of the company's obligation made to the state after it moved here to invest a total of $120 ...
Schwäbische16d
Glaube an die Zukunft: Boehringer Ingelheim investiert weiter
„Wir wachsen weiter“, sagte Thomas Reith, Standortleiter von Boehringer Ingelheim beim Herbst-Pressegespräch ... gerade ganz gewaltig, um die Produkte marktfertig zu machen“, so Reith.
Schwäbische17d
Boehringer hofft auf Durchbruch bei Schizophrenie-Präparat
Investitionen in Ingelheim und Biberach Baulich investiert Boehringer stark am Hauptsitz ... in der insbesondere flüssige Produkte abgefüllt werden (Liquid Launch Factory).
FierceBiotech10d
Boehringer Ingelheim drops obesity drug from Gubra partnership
Boehringer Ingelheim has halted development of an obesity drug from Gubra that it originally pledged to advance back in 2017, ...
Finanznachrichten3d
Aktuelle Empfehlungen zur BOEHRINGER INGELHEIM
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den ...
FierceBiotech27d
Notable Labs files for bankruptcy, ending ambitions for Boehringer cancer drug
Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the oncology-focused platform company’s decision to file for bankruptcy. Notable's ...
‘Sick day’ on the clock: CT Biopharma firm expands patient simulations to spark creativity, empathy
Spending the day facing the challenges of kidney patients helps workers at a CT pharmaceutical company understand disease and ...
Business Wire1mon
Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment
INGELHEIM, Germany & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Boehringer Ingelheim and Circle Pharma (Circle) announce a new research collaboration and license agreement with the shared goal ...
WebMD6mon
What It Means to Be Patient-Centric
She's currently the Chief Medical Officer and Head of Medicine at Boehringer Ingelheim. Well, Dr. Hinsch Gylvin. Thanks for joining me today. That really has changed. So first and foremost ...
Financial Post27d
Boehringer Ingelheim and WHO Foundation join forces to promote equitable access to healthcare and increase efforts for suicide prevention
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...